3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
30
Glioblastoma
28
Breast Neoplasms
19
Lung Neoplasms
17
Carcinoma, Non-Small-Cell Lung
17
Oropharyngeal Neoplasms
14
Squamous Cell Carcinoma of Head and Neck
11
Sarcoma
10
Glioma
10
Esophageal Neoplasms
10
Brain Neoplasms
10
Urinary Bladder Neoplasms
9
Astrocytoma
9
Gliosarcoma
8
Triple Negative Breast Neoplasms
7
Neoplasm Metastasis
7
Mouth Neoplasms
7
Uterine Cervical Neoplasms
6
Rectal Neoplasms
6
Melanoma
6
Head and Neck Neoplasms
6
Carcinoma, Hepatocellular
6
Carcinoma
6
Adenocarcinoma Of Esophagus
6
Stomach Neoplasms
5
Pancreatic Neoplasms
5
Neoplasms
5
Laryngeal Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Carcinoma, Squamous Cell
5
Interventions
Nivolumab
6
Specimen Handling
5
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
Cisplatin
4
pembrolizumab
3
cabozantinib
3
avelumab
3
Ipilimumab
3
Carboplatin
3
CTLA-4 Antigen
3
enfortumab vedotin
2
Immunoglobulin G
2
Disulfides
2
Biopsy
2
tremelimumab
1
trastuzumab deruxtecan
1
tocilizumab
1
tamibarotene
1
relatlimab
1
eribulin
1
erdafitinib
1
durvalumab
1
atezolizumab
1
Propranolol
1
Platinum
1
Leucovorin
1
Lenalidomide
1
Fluorouracil
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urethral Neoplasms
×
Radiation
×
1 year
×
Clear all
No trials found.